<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(15)</volume><submitter>Overtchouk P</submitter><pubmed_abstract>&lt;h4>Aims&lt;/h4>The aim of this study was to determine the prognostic impact of pre- and post-PCI TIMI flow grade and TIMI myocardial perfusion grade (TMPG) in a well-defined group of patients with cardiogenic shock due to acute myocardial infarction.&lt;h4>Methods and results&lt;/h4>Patients with infarct-related cardiogenic shock randomised into the CULPRIT-SHOCK trial were included in the angiographic predictor analysis whenever their TIMI flow grade or TMPG was available in the core lab database (96.9% of cases). A multivariable logistic regression analysis, adjusted on non-angiographic covariates, was performed to investigate whether TIMI flow grade or TMPG was independently associated with all-cause mortality or renal replacement therapy up to one year. Pre-PCI TIMI flow grade and TMPG did not impact on mortality. When analysed in separate multivariable models, post-PCI TIMI 3 flow and TMPG grade 3 were both significantly associated with reduced risk of 30-day mortality: aOR 0.61 (95% CI: 0.38-0.97, p=0.037) and 0.46 (95% CI: 0.29-0.72, p&lt;0.001), respectively. When considered in the same multivariable model, only TMPG was significantly associated with 30-day mortality (aOR 0.38 [0.20-0.71], p=0.002), the 30-day composite of all-cause mortality and renal replacement therapy (aOR 0.34 [0.18-0.66], p=0.001) and mortality at one-year follow-up (aOR 0.46 [0.24-0.88], p=0.02).&lt;h4>Conclusions&lt;/h4>Post-PCI TIMI flow grade and TMPG are associated with mortality after PCI. TMPG is a better discriminator, supporting microcirculation rather than epicardial reperfusion for prognosis estimation.</pubmed_abstract><journal>EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology</journal><pagination>e1237-e1244</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9724985</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy.</pubmed_title><pmcid>PMC9724985</pmcid><pubmed_authors>Silvain J</pubmed_authors><pubmed_authors>Sandri M</pubmed_authors><pubmed_authors>El Kasty M</pubmed_authors><pubmed_authors>Vicaut E</pubmed_authors><pubmed_authors>Brugier D</pubmed_authors><pubmed_authors>Zeymer U</pubmed_authors><pubmed_authors>Thiele H</pubmed_authors><pubmed_authors>Zeitouni M</pubmed_authors><pubmed_authors>Montalescot G</pubmed_authors><pubmed_authors>Vignolles N</pubmed_authors><pubmed_authors>Rouanet S</pubmed_authors><pubmed_authors>Desch S</pubmed_authors><pubmed_authors>Noc M</pubmed_authors><pubmed_authors>Huber K</pubmed_authors><pubmed_authors>Hauguel-Moreau M</pubmed_authors><pubmed_authors>Bertin B</pubmed_authors><pubmed_authors>Fuernau G</pubmed_authors><pubmed_authors>Collet JP</pubmed_authors><pubmed_authors>Guedeney P</pubmed_authors><pubmed_authors>Kerneis M</pubmed_authors><pubmed_authors>Barthelemy O</pubmed_authors><pubmed_authors>Hage G</pubmed_authors><pubmed_authors>Overtchouk P</pubmed_authors><pubmed_authors>Collaborators</pubmed_authors></additional><is_claimable>false</is_claimable><name>Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy.</name><description>&lt;h4>Aims&lt;/h4>The aim of this study was to determine the prognostic impact of pre- and post-PCI TIMI flow grade and TIMI myocardial perfusion grade (TMPG) in a well-defined group of patients with cardiogenic shock due to acute myocardial infarction.&lt;h4>Methods and results&lt;/h4>Patients with infarct-related cardiogenic shock randomised into the CULPRIT-SHOCK trial were included in the angiographic predictor analysis whenever their TIMI flow grade or TMPG was available in the core lab database (96.9% of cases). A multivariable logistic regression analysis, adjusted on non-angiographic covariates, was performed to investigate whether TIMI flow grade or TMPG was independently associated with all-cause mortality or renal replacement therapy up to one year. Pre-PCI TIMI flow grade and TMPG did not impact on mortality. When analysed in separate multivariable models, post-PCI TIMI 3 flow and TMPG grade 3 were both significantly associated with reduced risk of 30-day mortality: aOR 0.61 (95% CI: 0.38-0.97, p=0.037) and 0.46 (95% CI: 0.29-0.72, p&lt;0.001), respectively. When considered in the same multivariable model, only TMPG was significantly associated with 30-day mortality (aOR 0.38 [0.20-0.71], p=0.002), the 30-day composite of all-cause mortality and renal replacement therapy (aOR 0.34 [0.18-0.66], p=0.001) and mortality at one-year follow-up (aOR 0.46 [0.24-0.88], p=0.02).&lt;h4>Conclusions&lt;/h4>Post-PCI TIMI flow grade and TMPG are associated with mortality after PCI. TMPG is a better discriminator, supporting microcirculation rather than epicardial reperfusion for prognosis estimation.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-05T15:44:40.799Z</modification><creation>2025-04-05T15:44:40.799Z</creation></dates><accession>S-EPMC9724985</accession><cross_references><pubmed>32624460</pubmed><doi>10.4244/eij-d-20-00139</doi><doi>10.4244/EIJ-D-20-00139</doi></cross_references></HashMap>